Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed.

1. Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma.Medicine · 2017
   Trial
2. Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity.International journal of molecular sciences · 2021
   Article
3. Beyond Cisplatin: Combination Therapy with Arsenic Trioxide.Inorganica chimica acta · 2019
   Article
4. Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment.International journal of nanomedicine · 2019
   Review
5. β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1.Stem cells translational medicine · 2017
   Article
6. Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.Cancer gene therapy · 2016
   Article
7. Arsenic Disruption of DNA Damage Responses-Potential Role in Carcinogenesis and Chemotherapy.Biomolecules · 2015
   Review
8. Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells.International journal of clinical and experimental medicine · 2015
   Article
9. Arsenic Trioxide Combined with VCMP or VAD Chemotherapy in Patients with Refractory or Relapsed Multiple Myeloma in a Single Institution of China.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2014
   Article
10. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.Cancer gene therapy · 2012
    Article
11. Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines.Oncology letters · 2012
    Article
12. Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses.Toxicological sciences : an official journal of the Society of Toxicology · 2012
    Article
13. Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells.Cancer gene therapy · 2011
    Article
14. Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC).Journal of ovarian research · 2011
    Article
15. Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells.Neoplasia (New York, N.Y.) · 2010
    Article
16. Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.Journal of ovarian research · 2009
    Article
17. Serum from rabbit orally administered cobra venom inhibits growth of implanted hepatocellular carcinoma cells in mice.World journal of gastroenterology · 2003
    Article
18. Synergistic effects of nimesulide and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice.World journal of gastroenterology · 2003
    Article
19. Synergistic effect of cell differential agent-II and arsenic trioxide on induction of cell cycle arrest and apoptosis in hepatoma cells.World journal of gastroenterology · 2003
    Article
20. Nitric oxide and calcium ions in apoptotic esophageal carcinoma cells induced by arsenite.World journal of gastroenterology · 2002
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as